May 21, 2024

Bionpa

You are Your Only Limit

Branched chemically modified poly(A) tails enhance the translation capacity of mRNA

8 min read
  • Sahin, U., Karikó, K. & Türeci, Ö. mRNA-based therapeutics—developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759–780 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Weng, Y. et al. The challenge and prospect of mRNA therapeutics landscape. Biotechnol. Adv. 40, 107534 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rohner, E., Yang, R., Foo, K. S., Goedel, A. & Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Walsh, E. E. et al. Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates. N. Engl. J. Med. 383, 2439–2450 (2020)

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Collén, A. et al. VEGFA mRNA for regenerative treatment of heart failure. Nat. Rev. Drug Discov. 21, 79–80 (2022).

    Article 
    PubMed 

    Google Scholar
     

  • Mullard, A. mRNA-based drug approaches phase I milestone. Nat. Rev. Drug Discov. 15, 595 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • A study of VERVE-101 in patients with familial hypercholesterolemia and cardiovascular disease. Clinicaltrials.gov https://clinicaltrials.gov/ct2/show/NCT05398029?term=verve101&draw=2&rank=1 (2023).

  • Rybakova, Y. et al. mRNA delivery for therapeutic anti-HER2 antibody expression in vivo. Mol. Ther. 27, 1415–1423 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gillmore, J. D. et al. CRISPR–Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493–502 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ramaswamy, S. et al. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc. Natl Acad. Sci. USA 114, E1941–E1950 (2017).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang, L. et al. Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia. Nat. Commun. 11, 5339 (2020).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).

    Article 
    PubMed 

    Google Scholar
     

  • Karikó, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • Kormann, M. S. D. et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol. 29, 154–157 (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Leppek, K. et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 13, 1536 (2022).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Asrani, K. H. et al. Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA. RNA Biol. 15, 756–762 (2018).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).

    Article 
    ADS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01393-0 (2022).

  • Schlake, T., Thess, A., Thran, M. & Jordan, I. mRNA as novel technology for passive immunotherapy. Cell. Mol. Life Sci. 76, 301–328 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Thess, A. et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol. Ther. 23, 1456–1464 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Koch, A., Aguilera, L., Morisaki, T., Munsky, B. & Stasevich, T. J. Quantifying the dynamics of IRES and cap translation with single-molecule resolution in live cells. Nat. Struct. Mol. Biol. 27, 1095–1104 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bloom, K., van den Berg, F. & Arbuthnot, P. Self-amplifying RNA vaccines for infectious diseases. Gene Ther. 28, 117–129 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sonenberg, N. & Hinnebusch, A. G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731–745 (2009).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kahvejian, A., Roy, G. & Sonenberg, N. The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA translation. Cold Spring Harb. Symp. Quant. Biol. 66, 293–300 (2001).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hinnebusch, A. G. The scanning mechanism of eukaryotic translation initiation. Annu. Rev. Biochem. 83, 779–812 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Eisen, T. J. et al. The dynamics of cytoplasmic mRNA metabolism. Mol. Cell 77, 786–799.e10 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wang, Z., Day, N., Trifillis, P. & Kiledjian, M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol. Cell. Biol. 19, 4552–4560 (1999).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mangus, D. A., Evans, M. C. & Jacobson, A. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol. 4, 223 (2003).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bernstein, P., Peltz, S. W. & Ross, J. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9, 659–670 (1989).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aditham, A. et al. Chemically modified mocRNAs for highly efficient protein expression in mammalian cells. ACS Chem. Biol. 17, 3352–3366 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sawazaki, R. et al. Characterization of the multimeric structure of poly(A)-binding protein on a poly(A) tail. Sci. Rep. 8, 1455 (2018).

    Article 
    ADS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kühn, U. & Pieler, T. Xenopus poly(A) binding protein: functional domains in RNA binding and protein-protein interaction. J. Mol. Biol. 256, 20–30 (1996).

    Article 
    PubMed 

    Google Scholar
     

  • Coombes, C. E. & Boeke, J. D. An evaluation of detection methods for large lariat RNAs. RNA 11, 323–331 (2005).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Katolik, A. et al. Regiospecific solid-phase synthesis of branched oligoribonucleotides that mimic intronic lariat RNA intermediates. J. Org. Chem. 79, 963–975 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Escorihuela, J. et al. Direct covalent attachment of DNA microarrays by rapid thiol-ene “click” chemistry. Bioconjug. Chem. 25, 618–627 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Greenberg, M. M. Attachment of reporter and conjugate groups to the 3′ termini of oligonucleotides. Curr. Protoc. Nucleic Acid Chem. https://doi.org/10.1002/0471142700.nc0405s02 (2001).

  • El-Sagheer, A. H. & Brown, T. Single tube gene synthesis by phosphoramidate chemical ligation. Chem. Commun. 53, 10700–10702 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Kalinowski, M. et al. Phosphoramidate ligation of oligonucleotides in nanoscale structures. ChemBioChem 17, 1150–1155 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Ehret, F., Zhou, C. Y., Alexander, S. C., Zhang, D. & Devaraj, N. K. Site-specific covalent conjugation of modified mRNA by tRNA guanine transglycosylase. Mol. Pharm. 15, 737–742 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang, D. et al. Site-specific and enzymatic cross-linking of sgRNA enables wavelength-selectable photoactivated control of CRISPR gene editing. J. Am. Chem. Soc. 144, 4487–4495 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fantoni, N. Z., El-Sagheer, A. H. & Brown, T. A hitchhiker’s guide to click-chemistry with nucleic acids. Chem. Rev. 121, 7122–7154 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Warminski, M., Kowalska, J. & Jemielity, J. Solid-phase synthesis of RNA 5′-azides and their application for labeling, ligation, and cyclization via click chemistry. Curr. Protoc. Nucleic Acid Chem. 82, e112 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kühn, U. & Wahle, E. Structure and function of poly(A) binding proteins. Biochim. Biophys. Acta 1678, 67–84 (2004).

    Article 
    PubMed 

    Google Scholar
     

  • Deo, R. C., Bonanno, J. B., Sonenberg, N. & Burley, S. K. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell 98, 835–845 (1999).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592, 283–289 (2021).

    Article 
    ADS 
    CAS 
    PubMed 

    Google Scholar
     

  • Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638–646 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wang, X. et al. Three-dimensional intact-tissue sequencing of single-cell transcriptional states. Science 361, eaat5691 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zeng, H. et al. Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease. Nat. Neurosci. 26, 430–446 (2023).

    CAS 
    PubMed 

    Google Scholar
     

  • Zeng, H. et al. Spatially resolved single-cell translatomics at molecular resolution. Science 380, eadd3067 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xiang, K. & Bartel, D. P. The molecular basis of coupling between poly(A)-tail length and translational efficiency. eLife 10, e66493 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li, X. et al. Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273, 34970–34975 (1998).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nicholson-Shaw, A. L., Kofman, E. R., Yeo, G. W. & Pasquinelli, A. E. Nuclear and cytoplasmic poly(A) binding proteins (PABPs) favor distinct transcripts and isoforms. Nucleic Acids Res. 50, 4685–4702 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Perzanowska, O., Smietanski, M., Jemielity, J. & Kowalska, J. Chemically modified poly(A) analogs targeting PABP: structure activity relationship and translation inhibitory properties. Chemistry 28, e202201115 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Görlach, M., Burd, C. G. & Dreyfuss, G. The mRNA poly(A)-binding protein: localization, abundance, and RNA-binding specificity. Exp. Cell. Res. 211, 400–407 (1994).

    Article 
    PubMed 

    Google Scholar
     

  • Schäfer, I. B. et al. Molecular basis for poly(A) RNP architecture and recognition by the Pan2–Pan3 deadenylase. Cell 177, 1619–1631.e21 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Webster, M. W. et al. mRNA deadenylation is coupled to translation rates by the differential activities of Ccr4–Not nucleases. Mol. Cell 70, 1089–1100.e8 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dehlin, E., Wormington, M., Körner, C. G. & Wahle, E. Cap-dependent deadenylation of mRNA. EMBO J. 19, 1079–1086 (2000).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ruud, K. A., Kuhlow, C., Goss, D. J. & Browning, K. S. Identification and characterization of a novel cap-binding protein from Arabidopsis thaliana. J. Biol. Chem. 273, 10325–10330 (1998).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Shestakova, E. D., Smirnova, V. V., Shatsky, I. N. & Terenin, I. M. Specific mechanisms of translation initiation in higher eukaryotes: the eIF4G2 story. RNA 29, 282–299 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ho, J. J. D. et al. Systemic reprogramming of translation efficiencies on oxygen stimulus. Cell Rep. 14, 1293–1300 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Moerke, N. J. et al. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128, 257–267 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jang, D.-I. et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ 172, 367–379 (2005).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kumar, A., Zhang, J. & Yu, F.-S. X. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology 117, 11–21 (2006).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Okahira, S. et al. Interferon-beta induction through Toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol. 24, 614–623 (2005).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949–957 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Robson, A. Three different therapies to target PCSK9. Nat. Rev. Cardiol. 18, 541 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nelson, C. E. et al. Long-term evaluation of AAV–CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427–432 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429–434 (2021).

    Article 
    ADS 
    CAS 
    PubMed 

    Google Scholar
     

  • Qiu, M. et al. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3. Proc. Natl Acad. Sci. USA 118, e2020401118 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou, J. et al. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting. FEBS J. 281, 1717–1725 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Park, J. et al. Short poly(A) tails are protected from deadenylation by the LARP1–PABP complex. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-00930-y (2023).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Arevalo, C. P. et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science 378, 899–904 (2022).

    Article 
    ADS 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Foy, S. P. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687–69 (2023).

  • Dong, Y. et al. DNA functional materials assembled from branched DNA: design, synthesis, and applications. Chem. Rev. 120, 9420–9481 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Horn, T., Chang, C. A. & Urdea, M. S. Chemical synthesis and characterization of branched oligodeoxyribonucleotides (bDNA) for use as signal amplifiers in nucleic acid quantification assays. Nucleic Acids Res. 25, 4842–4849 (1997).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen, H. et al. Branched, chemically modified poly(A) tails enhance the translation capacity of mRNA. Sequence Read Archive https://www.ncbi.nlm.nih.gov/sra/PRJNA1072971 (2024).

  • Anzalone, A. V. et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat. Biotechnol. 40, 731–740 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • bionpa.com All rights reserved. | Newsphere by AF themes.